0

CARBATROL از شرکت TAKEDA PHARMS USA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CARBATROL از شرکت TAKEDA PHARMS USA

New Drug Application (NDA): 020712

Company: TAKEDA PHARMS USA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CARBATROL CARBAMAZEPINE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes No
CARBATROL CARBAMAZEPINE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes Yes
CARBATROL CARBAMAZEPINE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

AB

Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/30/1997 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/020712_carbatrol_toc.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/26/2018 SUPPL-36 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020712s036lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020712Orig1s036ltr.pdf

03/22/2013 SUPPL-35 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020712s032s035lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020712Orig1s032,s035ltr.pdf

08/22/2011 SUPPL-34 REMS-Modified

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020712s034ltr.pdf

03/22/2013 SUPPL-32 Labeling-Medication Guide

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020712s032s035lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020712Orig1s032,s035ltr.pdf

01/26/2011 SUPPL-31 REMS-Proposal, Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020712s031lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020712s031ltr.pdf

04/23/2009 SUPPL-30 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020712s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020712s030ltr.pdf

12/11/2007 SUPPL-29 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020712s029lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020712s029ltr.pdf

06/30/2006 SUPPL-25 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020712s025lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020712s025LTR.pdf

01/24/2006 SUPPL-24 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020712s024ltr.pdf

08/07/2002 SUPPL-16 Manufacturing (CMC)

Label is not available on this site.

02/21/2002 SUPPL-15 Manufacturing (CMC)

Label is not available on this site.

10/30/2001 SUPPL-14 Manufacturing (CMC)

Label is not available on this site.

08/08/2000 SUPPL-13 Manufacturing (CMC)

Label is not available on this site.

08/08/2000 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.

05/17/2001 SUPPL-11 Manufacturing (CMC)-Control

Label is not available on this site.

06/14/2000 SUPPL-10 Manufacturing (CMC)

Label is not available on this site.

01/19/2000 SUPPL-9 Manufacturing (CMC)-Control

Label is not available on this site.

11/08/1999 SUPPL-8 Manufacturing (CMC)-Packaging

Label is not available on this site.

12/22/1999 SUPPL-7 Manufacturing (CMC)

Label is not available on this site.

06/28/1999 SUPPL-6 Manufacturing (CMC)-Packaging

Label is not available on this site.

06/28/1999 SUPPL-5 Manufacturing (CMC)-Packaging

Label is not available on this site.

01/27/1999 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

01/27/1999 SUPPL-2 Manufacturing (CMC)-Control

Label is not available on this site.

07/24/1998 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
08/26/2018 SUPPL-36

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020712s036lbl.pdf
03/22/2013 SUPPL-35

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020712s032s035lbl.pdf
03/22/2013 SUPPL-32

Labeling-Medication Guide

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020712s032s035lbl.pdf
01/26/2011 SUPPL-31

REMS-Proposal

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020712s031lbl.pdf
01/26/2011 SUPPL-31

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020712s031lbl.pdf
04/23/2009 SUPPL-30

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020712s030lbl.pdf
12/11/2007 SUPPL-29

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020712s029lbl.pdf
06/30/2006 SUPPL-25

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020712s025lbl.pdf

CARBATROL

CAPSULE, EXTENDED RELEASE;ORAL; 200MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARBAMAZEPINE CARBAMAZEPINE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078986 APOTEX INC
CARBAMAZEPINE CARBAMAZEPINE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 076697 NOSTRUM LABS INC
CARBAMAZEPINE CARBAMAZEPINE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 201106 TARO
CARBAMAZEPINE CARBAMAZEPINE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078592 TEVA PHARMS
CARBATROL CARBAMAZEPINE 200MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020712 TAKEDA PHARMS USA

CAPSULE, EXTENDED RELEASE;ORAL; 300MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARBAMAZEPINE CARBAMAZEPINE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078986 APOTEX INC
CARBAMAZEPINE CARBAMAZEPINE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 076697 NOSTRUM LABS INC
CARBAMAZEPINE CARBAMAZEPINE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 201106 TARO
CARBAMAZEPINE CARBAMAZEPINE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078592 TEVA PHARMS
CARBATROL CARBAMAZEPINE 300MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020712 TAKEDA PHARMS USA

CAPSULE, EXTENDED RELEASE;ORAL; 100MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CARBAMAZEPINE CARBAMAZEPINE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078986 APOTEX INC
CARBAMAZEPINE CARBAMAZEPINE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 076697 NOSTRUM LABS INC
CARBAMAZEPINE CARBAMAZEPINE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 201106 TARO
CARBAMAZEPINE CARBAMAZEPINE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription No AB 078592 TEVA PHARMS
CARBATROL CARBAMAZEPINE 100MG CAPSULE, EXTENDED RELEASE;ORAL Prescription Yes AB 020712 TAKEDA PHARMS USA
حتما بخوانید : BETA-2 از شرکت NEPHRON
بخوانید  CYTOXAN از شرکت BAXTER HLTHCARE
برچسب‌ها:

نظرات کاربران